Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: Findings from a prospective cohort study from 2013 to 2020
Elise Jackson(British Columbia Centre on Substance Use), Brittany B. Dennis(McMaster University), Seonaid Nolan(University of British Columbia), Taras Reshetukha(Queens University), Samara Jinks‐Chang(Johns Hopkins University), M. Eugenia Socías(University of British Columbia), Leen Naji(Sheridan College), Nadia Fairbairn(British Columbia Centre on Substance Use), Tea Rosic(Children's Hospital of Eastern Ontario), Zainab Samaan(Queen's University), Olivia Brooks(University of British Columbia), Paxton Bach(University of British Columbia), Amy Chesney(Providence Health Care), Myanca Rodrigues(McMaster University)
Cited by 7
Related Papers
Obesity in adults: a clinical practice guideline
|Canadian Medical Association Journal|2020|1.4k
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes
|The Canadian Journal of Psychiatry|2024|329
Characterization of Environmental Sources of the Human and Animal Pathogen <i>Cryptococcus gattii</i> in British Columbia, Canada, and the Pacific Northwest of the United States
|Applied and Environmental Microbiology|2006|238
Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction
|Journal of General Internal Medicine|2019|150
Expansion of Antigen-Specific Regulatory T Cells with the Topical Vitamin D Analog Calcipotriol
|The Journal of Immunology|2009|148